(S)-6-(3-Methyl-1H-pyrazol-4-yl)-2-(quinuclidin-2-yl)thieno[3,2-d]pyrimidin-4(1H)-one, 99%
cas: 1330782-76-7 — see every product listed under this CAS number, including other names
(S)-6-(3-Methyl-1H-pyrazol-4-yl)-2-(quinuclidin-2-yl)thieno[3,2-d]pyrimidin-4(1H)-one, 99% (CAS 1330782-76-7) is a chemical reagent available from Chemat. Available pack sizes: 2mg, 5mg, 10mg, 25mg, 50mg, 100mg, 250mg, 1g. Offered by: BLDpharm.
| brand | BLDpharm |
|---|---|
| catalog number | BD01208232-2mg |
| cas | 1330782-76-7 |
| size | 2mg |
Need more information?
Ask us about this product — we're happy to help.
Available pack sizes
| brand | size | price | |
|---|---|---|---|
| BLDpharm | 2mg | 464.31 Pln | |
| BLDpharm | 5mg | 736.43 Pln | |
| BLDpharm | 10mg | 1169.61 Pln | |
| BLDpharm | 25mg | 1947.12 Pln | |
| BLDpharm | 50mg | 3063.39 Pln | |
| BLDpharm | 100mg | 4857.20 Pln | |
| BLDpharm | 250mg | 8217.13 Pln | |
| BLDpharm | 1g | 26144.15 Pln |
properties
| purity | 99% |
|---|---|
| delivery time | 1-2 weeks |
Simurosertib is an orally bioavailable inhibitor of cell division cycle 7 (cell division cycle 7-related protein kinase; CDC7), with potential antineoplastic activity. Upon administration, simurosertib binds to and inhibits CDC7; this prevents the initiation of DNA replication during mitosis, which causes cell cycle arrest and induces apoptosis. This inhibits cell growth in CDC7-overexpressing tumor cells.
Source: ChEBI
| Molecular formula | C17H19N5OS |
|---|---|
| Molecular weight | 341.4 g/mol |
| IUPAC name | 2-[(2S)-1-azabicyclo[2.2.2]octan-2-yl]-6-(5-methyl-1H-pyrazol-4-yl)-3H-thieno[3,2-d]pyrimidin-4-one |
| InChIKey | XGVXKJKTISMIOW-ZDUSSCGKSA-N |
| SMILES | CC1=C(C=NN1)C2=CC3=C(S2)C(=O)NC(=N3)[C@@H]4CC5CCN4CC5 |
Computed by PubChem (NCBI)